Directed axonal outgrowth using a propagating gradient of IGF-1.
Wonjae Lee1, Curtis W Frank, Jon Park
1Department of Neurosurgery, Stanford University, Stanford, CA, USA.
Advanced Materials (Deerfield Beach, Fla.)
|March 26, 2014
Summary
Researchers developed a biocompatible device to guide neuron axon regrowth. This device uses a linear insulin-like growth factor 1 (IGF-1) gradient to promote directed axon extension for neurological repair.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Regenerative Medicine
Background:
- Axon outgrowth requires precise temporospatial regulation for neural circuit formation.
- Neurological injuries and diseases often impair neuronal connectivity, necessitating methods for guided neuronal repair.
Purpose of the Study:
- To develop a biocompatible guidance device for directed axon outgrowth.
- To investigate the efficacy of a linear insulin-like growth factor 1 (IGF-1) gradient in guiding axon extension.
Main Methods:
- Construction of a novel biocompatible guidance device.
- Utilizing a linear propagation of an IGF-1 gradient to direct neuronal growth.
- In vitro assessment of axonal extension length and growth rate.
Main Results:
- Successful construction of the biocompatible guidance device.
- Demonstrated sequential direction of axon outgrowth by the IGF-1 gradient.
- Achieved extensive in vitro axonal extension exceeding 5 mm.
- Observed a consistent growth rate of approximately 1 mm/day.
Conclusions:
- The developed guidance device effectively directs axon outgrowth using a linear IGF-1 gradient.
- This technology holds potential for promoting neural re-connectivity in neurological injury and disease.
- The observed growth rate suggests feasibility for in vivo applications in neural repair.
